Opening Pandora's box in the UK: a hypothetical pharmacogenetic test for clozapine.

Spencer, Benjamin W J; Prainsack, Barbara; Rujescu, Dan; Giegling, Ina; Collier, David A; Gaughran, Fiona; MacCabe, James H; Barr, Cathy L; Sigurdsson, Engilbert; Stovring, Henrik; Malhotra, Anil K; Curran, Sarah R

Spencer, Benjamin W J; Prainsack, Barbara; Rujescu, Dan; Giegling, Ina; Collier, David A; Gaughran, Fiona; MacCabe, James H; Barr, Cathy L; Sigurdsson, Engilbert; Stovring, Henrik; Malhotra, Anil K; Curran, Sarah R.

Affiliation

Spencer BW; South London & Maudsley NHS Foundation Trust, London, UK.

Pharmacogenomics ; 14(15): 1907-14, 2013 Nov.

Article in En | MEDLINE | ID: mdl-24236489

Subject(s)

Antipsychotic Agents/adverse effects; Clozapine/adverse effects; Drug-Related Side Effects and Adverse Reactions/genetics; Schizophrenia/genetics; Clozapine/therapeutic use; Humans; Pharmacogenetics/methods; Schizophrenia/drug therapy; United Kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents / Clozapine / Drug-Related Side Effects and Adverse Reactions Type of study: Guideline Limits: Humans Country/Region as subject: Europa Language: En Journal: Pharmacogenomics Journal subject: FARMACOLOGIA / GENETICA MEDICA Year: 2013 Type: Article Affiliation country: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google